Literature DB >> 8564109

Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa.

A Di Stefano1, G Turato, P Maestrelli, C E Mapp, M P Ruggieri, A Roggeri, P Boschetto, L M Fabbri, M Saetta.   

Abstract

To investigate whether the airway inflammatory process is different in patients with chronic bronchitis with airflow limitation and those with chronic bronchitis without airflow limitation, we obtained bronchial biopsies from 14 subjects with chronic sputum production and fixed airway obstruction, and from 10 subjects with chronic sputum production and normal FEV1, all with a history of cigarette smoking. Paraffin-embedded and frozen bronchial biopsies were examined by immunohistochemistry to identify the number of neutrophils (neutrophil-elastase), eosinophils (antieosinophil cationic protein [EG-2]), mast cells (tryptase), T-lymphocytes (CD3), T-lymphocyte subpopulations (CD4 and CD8), B-lymphocytes, and macrophages (CD68) in the submucosa. Subjects with chronic bronchitis with airflow limitation had a greater number of T-lymphocytes (p < 0.01) and macrophages (p < 0.05) than subjects with chronic bronchitis without airflow limitation, whereas the T-lymphocyte subpopulations and the numbers of B-lymphocytes, neutrophils, eosinophils, and mast cells were similar in the two groups. When all the subjects were considered together, the number of T-lymphocytes correlated inversely with the values of FEV1 (r = 0.46, p < 0.02). In conclusion, airflow limitation in subjects with chronic bronchitis is associated with an increased number of T-lymphocytes and macrophages in the bronchial mucosa.

Entities:  

Mesh:

Year:  1996        PMID: 8564109     DOI: 10.1164/ajrccm.153.2.8564109

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  Neutrophilic infiltration within the airway smooth muscle in patients with COPD.

Authors:  S Baraldo; G Turato; C Badin; E Bazzan; B Beghé; R Zuin; F Calabrese; G Casoni; P Maestrelli; A Papi; L M Fabbri; M Saetta
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

2.  A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity.

Authors:  M W Lethbridge; D M Kemeny; J C Ratoff; B J O'Connor; C M Hawrylowicz; C J Corrigan
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Immunopathological changes in the airways of stable lung transplant recipients.

Authors:  G I Snell; C Ward; J W Wilson; B Orsida; T J Williams; E H Walters
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 4.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 5.  What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease?

Authors:  James C Hogg; John E McDonough; John V Gosselink; Shizu Hayashi
Journal:  Proc Am Thorac Soc       Date:  2009-12

6.  Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3.

Authors:  Steven G Kelsen; Mark O Aksoy; Mary Georgy; Richard Hershman; Rong Ji; Xiuxia Li; Matthew Hurford; Charalambos Solomides; Wissam Chatila; Victor Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

7.  Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Timothy Ramsay; Chun Zhang; Zafrira Avnur; Tania Nikolcheva; Anthony Quinn
Journal:  Respir Res       Date:  2010-04-22

Review 8.  Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.

Authors:  Kazutetsu Aoshiba; Atsushi Nagai
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

Review 9.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.